130 related articles for article (PubMed ID: 29499499)
1. Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease.
Gao Y; Wilson GR; Bozaoglu K; Elefanty AG; Stanley EG; Dottori M; Lockhart PJ
Stem Cell Res; 2018 Apr; 28():161-164. PubMed ID: 29499499
[TBL] [Abstract][Full Text] [Related]
2. Generation of a luciferase-expressing human embryonic stem cell line: NERCe002-A-2.
Peng Y; Xie M; Duan X; Hu L; Yu J; Zeng S; Wang Y; Ouyang Q; Lu G; Lin G; Sun Y
Stem Cell Res; 2018 Apr; 28():172-176. PubMed ID: 29501955
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human embryonic stem cell line, NERCe003-A-1, with lentivirus vector-mediated inducible CTNNB1 overexpression.
Wang Y; Yu J; Liu L; Li W; Duan X; Peng Y; Zeng S; Ouyang Q; Lu G; Lin G; Sun Y
Stem Cell Res; 2018 Apr; 28():61-65. PubMed ID: 29428849
[TBL] [Abstract][Full Text] [Related]
4. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-20.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):207-9. PubMed ID: 27345969
[TBL] [Abstract][Full Text] [Related]
5. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Herring A; Messana A; Bara AM; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):430-432. PubMed ID: 27879218
[TBL] [Abstract][Full Text] [Related]
6. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.
Hodges K; Brewer SS; Labbé C; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; van Gerpen JA; Ertekin-Taner N; Kantarci K; Lowe VJ; Parisi JE; Savica R; Graff-Radford J; Jones DT; Knopman DS; Petersen RC; Murray ME; Graff-Radford NR; Ferman TJ; Dickson DW; Wszolek ZK; Boeve BF; Ross OA; Lorenzo-Betancor O
Neurobiol Aging; 2016 Sep; 45():107-108. PubMed ID: 27459931
[TBL] [Abstract][Full Text] [Related]
7. Novel RAB39B loss-of-function mutation in patient with typical early-onset Parkinson's disease.
Jacobson JR; Piat C; Aksamit AJ; Patane' G; Ross OA; Savica R
Parkinsonism Relat Disord; 2024 Jun; 123():106038. PubMed ID: 38503262
[TBL] [Abstract][Full Text] [Related]
8. Generation of a FMR1 homozygous knockout human embryonic stem cell line (WAe009-A-16) by CRISPR/Cas9 editing.
Giri S; Purushottam M; Viswanath B; Muddashetty RS
Stem Cell Res; 2019 Aug; 39():101494. PubMed ID: 31280136
[TBL] [Abstract][Full Text] [Related]
9. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
[TBL] [Abstract][Full Text] [Related]
10. Generation of two ERF gene knockout human embryonic stem cell lines using CRISPR/Cas9 system.
Si L; Yang R; Liu J; Dong Y; Zhang H; Xu X
Stem Cell Res; 2019 Dec; 41():101644. PubMed ID: 31743839
[TBL] [Abstract][Full Text] [Related]
11. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.
Wilson GR; Sim JC; McLean C; Giannandrea M; Galea CA; Riseley JR; Stephenson SE; Fitzpatrick E; Haas SA; Pope K; Hogan KJ; Gregg RG; Bromhead CJ; Wargowski DS; Lawrence CH; James PA; Churchyard A; Gao Y; Phelan DG; Gillies G; Salce N; Stanford L; Marsh AP; Mignogna ML; Hayflick SJ; Leventer RJ; Delatycki MB; Mellick GD; Kalscheuer VM; D'Adamo P; Bahlo M; Amor DJ; Lockhart PJ
Am J Hum Genet; 2014 Dec; 95(6):729-35. PubMed ID: 25434005
[TBL] [Abstract][Full Text] [Related]
12. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
[TBL] [Abstract][Full Text] [Related]
13. Lack of RAB39B mutations in early-onset and familial Parkinson's disease in a Taiwanese cohort.
Lin HH; Wu RM; Lin HI; Chen ML; Tai CH; Lin CH
Neurobiol Aging; 2017 Feb; 50():169.e3-169.e4. PubMed ID: 27838047
[TBL] [Abstract][Full Text] [Related]
14. X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene.
Ciammola A; Carrera P; Di Fonzo A; Sassone J; Villa R; Poletti B; Ferrari M; Girotti F; Monfrini E; Buongarzone G; Silani V; Cinnante CM; Mignogna ML; D'Adamo P; Bonati MT
Parkinsonism Relat Disord; 2017 Nov; 44():142-146. PubMed ID: 28851564
[TBL] [Abstract][Full Text] [Related]
15. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
[TBL] [Abstract][Full Text] [Related]
16. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39.
Shetty DK; Inamdar MS
Stem Cell Res; 2016 Mar; 16(2):308-10. PubMed ID: 27345991
[TBL] [Abstract][Full Text] [Related]
17. A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification.
Shi CH; Zhang SY; Yang ZH; Yang J; Shang DD; Mao CY; Liu H; Hou HM; Shi MM; Wu J; Xu YM
Mov Disord; 2016 Dec; 31(12):1905-1909. PubMed ID: 27943471
[TBL] [Abstract][Full Text] [Related]
18. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.
Bara AM; Messana A; Herring A; Hazelbaker DZ; Eggan K; Barrett LE
Stem Cell Res; 2016 Sep; 17(2):441-443. PubMed ID: 27879221
[TBL] [Abstract][Full Text] [Related]
19. Generation of FHL2 homozygous knockout lines from human embryonic stem cells by CRISPR/Cas9-mediated ablation.
Chang CW; Chang CC; Hsia KC; Tsai SY
Stem Cell Res; 2018 Mar; 27():21-24. PubMed ID: 29291512
[TBL] [Abstract][Full Text] [Related]
20. Distribution of Parkinson's disease associated RAB39B in mouse brain tissue.
Gao Y; Wilson GR; Stephenson SEM; Oulad-Abdelghani M; Charlet-Berguerand N; Bozaoglu K; McLean CA; Thomas PQ; Finkelstein DI; Lockhart PJ
Mol Brain; 2020 Mar; 13(1):52. PubMed ID: 32228644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
